Literature DB >> 7539725

Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects.

J H Vingerhoets1, G L Vanham, L L Kestens, G G Penne, R L Colebunders, M J Vandenbruaene, J Goeman, P L Gigase, M De Boer, J L Ceuppens.   

Abstract

The CD28 receptor on CD4+ and CD8+ T cells interacts with B7 molecules on antigen-presenting cells (APC) to generate essential costimulatory signals. The cytolytic potential of CD8+ T cells could be linked to CD28 expression. Since HIV induces dysfunction of both CD4+ and CD8+ T cells, we evaluated CD28 expression and function in both subsets during HIV infection. CD28 expression on CD8+ T cells from HIV+ subjects was strongly reduced in a disease stage-related fashion. CD28- CD8+ T cells preferentially expressed CD57 and CD11b, but lacked CD26 and IL-2R alpha. The CD8+ T cells from the patients showed a significantly reduced proliferative response to co-stimulation with cell-bound anti-CD3 and B7. Nevertheless, when stimulated with plate-fixed anti-CD3, CD8+ T cells from HIV-infected subjects proliferated normally, and normal levels of IL-2R alpha and transferrin-receptor could be induced on CD28- CD8+ T cells from the patients. In addition, stimulation with plate-fixed anti-CD3 induced proliferative responses in highly purified CD28- CD8+ T cells from both HIV- and HIV+ persons. Furthermore, the increased cytotoxic activity of peripheral blood mononuclear cells (PBMC) from HIV+ subjects, measured in an anti-CD3 redirected assay, was predominantly exerted by CD28- CD57+ T cells. CD4+ T cells from the patients showed a slight but significant CD28 down-regulation and were slightly hyporesponsive to B7 co-stimulation. Decrease of CD28 on CD8+ T cells from HIV+ subjects is associated with an impaired response to co-stimulation via B7. CD28- CD8+ T cells from seropositives, however, are not completely inert, since they contain in vivo activated CTL and they can be additionally activated through a B7-independent stimulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539725      PMCID: PMC1534479          DOI: 10.1111/j.1365-2249.1995.tb03717.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  43 in total

1.  CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.

Authors:  M Azuma; M Cayabyab; D Buck; J H Phillips; L L Lanier
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

Review 2.  CD8+ cell anti-HIV activity: nonlytic suppression of virus replication.

Authors:  C Mackewicz; J A Levy
Journal:  AIDS Res Hum Retroviruses       Date:  1992-06       Impact factor: 2.205

3.  Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV infection: distinctive parameters of HIV-induced change.

Authors:  B Hofmann; P Nishanian; J L Fahey; I Esmail; A L Jackson; R Detels; W Cumberland
Journal:  Clin Immunol Immunopathol       Date:  1991-11

4.  CD28 ligation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity.

Authors:  S W Van Gool; M de Boer; J L Ceuppens
Journal:  J Immunol       Date:  1993-04-15       Impact factor: 5.422

5.  In situ expression of B7/BB1 on antigen-presenting cells and activated B cells: an immunohistochemical study.

Authors:  P Vandenberghe; J Delabie; M de Boer; C De Wolf-Peeters; J L Ceuppens
Journal:  Int Immunol       Date:  1993-03       Impact factor: 4.823

6.  Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection.

Authors:  G Vanham; L Kestens; G Penne; C Goilav; P Gigase; R Colebunders; M Vandenbruaene; J Goeman; G van der Groen; J L Ceuppens
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

7.  CD28- T lymphocytes. Antigenic and functional properties.

Authors:  M Azuma; J H Phillips; L L Lanier
Journal:  J Immunol       Date:  1993-02-15       Impact factor: 5.422

8.  CD11b (Mac-1): a marker for CD8+ cytotoxic T cell activation and memory in virus infection.

Authors:  H I McFarland; S R Nahill; J W Maciaszek; R M Welsh
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

9.  Antibody and B7/BB1-mediated ligation of the CD28 receptor induces tyrosine phosphorylation in human T cells.

Authors:  P Vandenberghe; G J Freeman; L M Nadler; M C Fletcher; M Kamoun; L A Turka; J A Ledbetter; C B Thompson; C H June
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

10.  Functional expression of B7/BB1 on activated T lymphocytes.

Authors:  M Azuma; H Yssel; J H Phillips; H Spits; L L Lanier
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

View more
  29 in total

1.  CD28 costimulation and CD28 expression in T lymphocyte subsets in HIV-1 infection with and without progression to AIDS.

Authors:  H Choremi-Papadopoulou; N Panagiotou; E Samouilidou; F Kontopidou; V Viglis; A Antoniadou; J Kosmidis; T Kordossis
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

2.  Expression of CD28 and CD38 by CD8+ T lymphocytes in HIV-1 infection correlates with markers of disease severity and changes towards normalization under treatment. The Swiss HIV Cohort Study.

Authors:  P Bürgisser; C Hammann; D Kaufmann; M Battegay; O T Rutschmann
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

3.  Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts.

Authors:  T Messele; M Abdulkadir; A L Fontanet; B Petros; D Hamann; M Koot; M T Roos; P T Schellekens; F Miedema; T F Rinke de Wit
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

4.  Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors.

Authors:  G M Gillespie; M R Wills; V Appay; C O'Callaghan; M Murphy; N Smith; P Sissons; S Rowland-Jones; J I Bell; P A Moss
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Impact of opportunistic Mycobacterium tuberculosis infection on the phenotype of peripheral blood T cells of AIDS patients.

Authors:  Germán Bernal-Fernández; Carlos Hermida; Patricia Espinosa-Cueto; Ana Cristina Cubilla-Tejeda; Jesús Fidel Salazar-González; Librado Ortiz-Ortiz; Rosario Leyva-Meza; Hugo Diaz-Silvestre; Raul Mancilla
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

6.  Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes.

Authors:  Lorraine Yeo; Alyssa Woodwyk; Sanjana Sood; Anna Lorenc; Martin Eichmann; Irma Pujol-Autonell; Rosella Melchiotti; Ania Skowera; Efthymios Fidanis; Garry M Dolton; Katie Tungatt; Andrew K Sewell; Susanne Heck; Alka Saxena; Craig A Beam; Mark Peakman
Journal:  J Clin Invest       Date:  2018-07-16       Impact factor: 14.808

7.  The CD28/HLA-DR expressions on CD4+T but not CD8+T cells are significant predictors for progression to AIDS.

Authors:  Byeong-Sun Choi; Yong-Keun Park; Joo-Shil Lee
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

8.  Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation.

Authors:  L A Trimble; P Shankar; M Patterson; J P Daily; J Lieberman
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

9.  Modulation of T lymphocyte replicative senescence via TNF-{alpha} inhibition: role of caspase-3.

Authors:  Stanley T Parish; Jennifer E Wu; Rita B Effros
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

10.  Significantly skewed memory CD8+ T cell subsets in HIV-1 infected infants during the first year of life.

Authors:  Nazma Mansoor; Brian Abel; Thomas J Scriba; Jane Hughes; Marwou de Kock; Michele Tameris; Sylvia Mlenjeni; Lea Denation; Francesca Little; Sebastian Gelderbloem; Anthony Hawkridge; W Henry Boom; Gilla Kaplan; Gregory D Hussey; Willem A Hanekom
Journal:  Clin Immunol       Date:  2008-11-08       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.